Skip to main content
NCBI home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1973 Sep;49(575):630–636. doi: 10.1136/pgmj.49.575.630

Complement in nephritis.

R Gabriel
PMCID: PMC2495759  PMID: 4133045

Full text

PDF
630

Images in this article

632Fig. 4
on p.632
632Fig. 5
on p.632
633Fig. 6
on p.633
633Fig. 7
on p.633
634Fig. 8
on p.634

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alper C. A., Rosen F. S. Alper CA, Rosen FS: Studies of the in vivo behavior of human C'3 in normal subjects and patients. J Clin Invest. 1967 Dec;46(12):2021–2034. doi: 10.1172/JCI105691. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. BOLTAX A. J., FISCHEL E. E. Serologic tests for inflammation; serum complement, c-reactive protein and erythrocyte sedimentation rate in myocardial infarction. Am J Med. 1956 Mar;20(3):418–427. doi: 10.1016/0002-9343(56)90127-9. [DOI] [PubMed] [Google Scholar]
  3. Berger J., Yaneva H., Antoine B. Application de l'immunofluorescence à la pathologie renale. II. Etude immunohistochimique des lésions glomérulaires. J Urol Nephrol (Paris) 1969 Apr-May;75(4):269–281. [PubMed] [Google Scholar]
  4. Cameron J. S., Glasgow E. F., Ogg C. S., White R. H. Membranoproliferative glomerulonephritis and persistent hypocomplementaemia. Br Med J. 1970 Oct 3;4(5726):7–14. doi: 10.1136/bmj.4.5726.7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Cameron J. S., Ogg C. S., White R. H., Glasgow E. F. The clinical features and prognosis of patients with normocomplementemic mesangiocapillary glomerulonephritis. Clin Nephrol. 1973 Jan-Feb;1(1):8–13. [PubMed] [Google Scholar]
  6. DIXON F. J., VAZQUEZ J. J., WEIGLE W. O., COCHRANE C. G. Pathogenesis of serum sickness. AMA Arch Pathol. 1958 Jan;65(1):18–28. [PubMed] [Google Scholar]
  7. DUNCAN D. A., DRUMMOND K. N., MICHAEL A. F., VERNIER R. L. PULMONARY HEMORRHAGE AND GLOMERULONEPHRITIS. REPORT OS SIX CASES AND STUDY OF THE RENAL LESION BY THE FLUORESCENT ANTIBODY TECHNIQUE AND ELECTRON MICROSCOPY. Ann Intern Med. 1965 May;62:920–938. doi: 10.7326/0003-4819-62-5-920. [DOI] [PubMed] [Google Scholar]
  8. GOTOFF S. P., FELLERS F. X., VAWTER G. F., JANEWAY C. A., ROSEN F. S. THE BETA-1C GLOBULIN IN CHILDHOOD NEPHROTIC SYNDROME: LABORATORY DIAGNOSIS OF PROGRESSIVE GLOMERULONEPHRITIS. N Engl J Med. 1965 Sep 2;273:524–529. doi: 10.1056/NEJM196509022731004. [DOI] [PubMed] [Google Scholar]
  9. Gabriel R., Glynn A. A., Joekes A. M. Raised complement in nephritis: prognostic significance. Lancet. 1972 Jul 8;2(7767):55–57. doi: 10.1016/s0140-6736(72)91549-8. [DOI] [PubMed] [Google Scholar]
  10. Gutman R. A., Striker G. E., Gilliland B. C., Cutler R. E. The immune complex glomerulonephritis of bacterial endocarditis. Medicine (Baltimore) 1972 Jan;51(1):1–25. doi: 10.1097/00005792-197201000-00001. [DOI] [PubMed] [Google Scholar]
  11. HAMMER D. K., DIXON F. J. Experimental glomerulonephritis. II. Immunologic events in the pathogenesis of nephrotoxic serum nephritis in the rat. J Exp Med. 1963 Jun 1;117:1019–1034. doi: 10.1084/jem.117.6.1019. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Lagrue G., Brécy H., Hartmann L. La complémenturie dans les glomérulopathies humaines. Rev Fr Etud Clin Biol. 1969 Apr;14(4):346–353. [PubMed] [Google Scholar]
  13. Lam C. N., McNeish A. S., Gibson A. A. Nephrotic syndrome associated with complement deficiency and Staphylococcus albus bacteraemia. Scott Med J. 1969 Mar;14(3):86–88. doi: 10.1177/003693306901400305. [DOI] [PubMed] [Google Scholar]
  14. Lambert P. H., Dixon F. J. Pathogenesis of the glomerulonephritis of NZB/W mice. J Exp Med. 1968 Mar 1;127(3):507–522. doi: 10.1084/jem.127.3.507. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. McGiven A. R., Hicks J. D. The development of renal lesions in NZB-NZW mice immunohistological studies. Br J Exp Pathol. 1967 Jun;48(3):302–304. [PMC free article] [PubMed] [Google Scholar]
  16. Müller-Eberhard H. J., Götze O. C3 proactivator convertase and its mode of action. J Exp Med. 1972 Apr 1;135(4):1003–1008. doi: 10.1084/jem.135.4.1003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Ngu J. L., Soothill J. F. Immunoconglutinin and complement changes in children with acute nephritis. Clin Exp Immunol. 1969 Dec;5(6):557–566. [PMC free article] [PubMed] [Google Scholar]
  18. Peters D. K., Martin A., Weinstein A., Cameron J. S., Barratt T. M., Ogg C. S., Lachmann P. J. Complement studies in membrano-proliferative glomerulonephritis. Clin Exp Immunol. 1972 Jul;11(3):311–320. [PMC free article] [PubMed] [Google Scholar]
  19. Pickering R. J., Gewurz H., Good R. A. Complement inactivation by serum from patients with acute and hypocomplementemic chronic glomerulonephritis. J Lab Clin Med. 1968 Aug;72(2):298–307. [PubMed] [Google Scholar]
  20. Pickering R. J., Herdman R. C., Michael A. F., Vernier R. L., Gewurz H., Fish A. J., Good R. A. Chronic glomerulonephritis associated with low serum complement activity (chronic hypocomplementemic glomerulonephritis). Medicine (Baltimore) 1970 May;49(3):207–226. doi: 10.1097/00005792-197005000-00002. [DOI] [PubMed] [Google Scholar]
  21. Schur P. H., Sandson J. Immunologic factors and clinical activity in systemic lupus erythematosus. N Engl J Med. 1968 Mar 7;278(10):533–538. doi: 10.1056/NEJM196803072781004. [DOI] [PubMed] [Google Scholar]
  22. Soothill J. F. Altered complement component C3A (beta-1C--beta-1A) in patients with glomerulonephritis. Clin Exp Immunol. 1967 Jan;2(1):83–92. [PMC free article] [PubMed] [Google Scholar]
  23. Spitzer R. E., Vallota E. H., Forristal J., Sudora E., Stitzel A., Davis N. C., West C. D. Serum C'3 lytic system in patients with glomerulonephritis. Science. 1969 Apr 25;164(3878):436–437. doi: 10.1126/science.164.3878.436. [DOI] [PubMed] [Google Scholar]
  24. Thompson R. A. C3 inactivating factor in the serum of a patient with chronic hypocomplementaemic proliferative glomerulo-nephritis. Immunology. 1972 Jan;22(1):147–158. [PMC free article] [PubMed] [Google Scholar]
  25. Thompson R. A. IgG3 levels in patients with chronic membranoproliferative glomerulonephritis. Br Med J. 1972 Jan 29;1(5795):282–284. doi: 10.1136/bmj.1.5795.282. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Vallota E. H., Forristal J., Davis N. C., West C. D. The C3 nephritic factor and membranoproliferative nephritis: correlation of serum levels of the nephritic factor with C3 levels, with therapy, and with progression of the disease. J Pediatr. 1972 Jun;80(6):947–959. doi: 10.1016/s0022-3476(72)80006-4. [DOI] [PubMed] [Google Scholar]
  27. West C. D., McAdams A. J. Serum beta-1C globulin levels in persistent glomerulonephritis with low serum complement: variability unrelated to clinical course. Nephron. 1970;7(3):193–202. doi: 10.1159/000179822. [DOI] [PubMed] [Google Scholar]
  28. Williams D. G., Kourilsky O., Morel-Maroger L., Peters D. K. C3 breakdown by serum from patients with acute post-streptococcal nephritis. Lancet. 1972 Aug 19;2(7773):360–361. doi: 10.1016/s0140-6736(72)91740-0. [DOI] [PubMed] [Google Scholar]
  29. Williams D. G., Lachmann P. J., Charlesworth J. A., Peters D. K. Role of C3b in the breakdown of C3 in hypocomplementaemic mesangiocapillary glomerulonephritis. Lancet. 1973 Mar 3;1(7801):447–449. doi: 10.1016/s0140-6736(73)91877-1. [DOI] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES